INDs Transferred from Statera Biopharma Advance Entolimod for ARS Along Regulatory Pathway and Enable Pursuit of Clinical Trial Program in Neutropenia and Lymphocyte Exhaustion FREMONT, ...
SAN ANTONIO, TX / ACCESS Newswire / March 26, 2026 / Tivic Health Systems Inc. (Nasdaq:TIVC), a clinical-stage immunotherapeutics company, today announced it has entered into an agreement with the ...
Researchers created a bismuth coordinated melanin material that provides in vivo physical radiation shielding and ROS ...
The FDA granted an orphan drug designation for the novel drug, NT-17, to treat people with acute radiation syndrome. The Food and Drug Administration (FDA) has granted Orphan Drug Designation for the ...
Initial presentation on January 26, 2026 showcased Entolimod's potential to mitigate and prevent both gastrointestinal and hematopoietic injury from ionizing radiation exposure. FREMONT, CA / ACCESS ...
Redhill Biopharma Ltd.'s opaganib hydrochloride (ABC-294640) has been selected by the Radiation and Nuclear Countermeasures Program (RNCP), of the National Institute of Allergy and Infectious Diseases ...
FREMONT, CA / ACCESS Newswire / January 28, 2026 / Tivic Health® Systems, Inc. (Nasdaq:TIVC), a late-stage immunotherapeutics company, today announced that it delivered an invited presentation at a ...
(RTTNews) - Pluri Inc. (PLUR), a biotechnology company specializing in cell-based solutions, announced on Monday that it is assessing its readiness to initiate mass production of PLX-R18, a potential ...
LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global radiation syndrome treatment market to grow at a CAGR of over 6% during the forecast period, according to their latest market research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results